SMLR News and Press, Semler Scientific Inc From 04/03/23

2023-04-03 12:43:23 ET Semler Scientific ( NASDAQ: SMLR ) is down 10% in Monday afternoon trading after CMS removed screening for peripheral artery disease (PAD) without complications from the Medicare Advantage risk adjustment model. The decision directly impacts...

2023-04-03 10:02:08 ET Gainers: Heska ( HSKA ) +20% . Heron Therapeutics ( HRTX ) +19% . InterCure ( INCR ) +17% . Innate Pharma ( IPHA ) +15% . Apellis Pharmaceuticals ( APLS ) +14% . Losers: OncoSec Medical ( ONCS...

Semler Scientific Comments on CMS Risk Adjustment Changes in the 2024 Medicare Advantage and Part D Final Rate Announcement PR Newswire SANTA CLARA, Calif. , April 3, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides t...

2023-03-21 19:27:07 ET Semler Scientific, Inc. (SMLR) Q4 2022 Results Conference Call March 21, 2023 04:30 PM EDT Company Participants Douglas Murphy-Chutorian - CEO, Corporate Secretary Wayne Pan - New CEO Renae Cormier - Head, Corporate Communication and Busine...

2023-03-21 17:00:29 ET Semler Scientific ( NASDAQ: SMLR ) said Tuesday Doug Murphy-Chutorian will step down as chief executive officer, but will continue to serve as a member of the board of directors at least through the remainder of his 2024 term. The co...

2023-03-21 16:14:56 ET Semler Scientific press release ( NASDAQ: SMLR ): Q4 GAAP EPS of $0.41 beats by $0.13 . Revenue of $13.79M (+19.5% Y/Y) beats by $0.69M . Q1 Outlook: For the quarter ended March 31, 2023, Semler Scientific expects continued profitabil...

Semler Scientific Reports Fourth Quarter and Full Year 2022 Financial Results PR Newswire 2022 Q4 and Full Year highlights compared to the corresponding period of 2021: Fourth quarter revenue was $13.8 million , an increase of 20% Fourth quarter net income ...

Semler Scientific Names Wayne T. Pan, M.D., Ph.D., M.B.A. as New CEO Effective April 3, 2023 PR Newswire SANTA CLARA, Calif. , March 21, 2023 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clini...

2023-03-20 17:35:36 ET Semler Scientific ( NASDAQ: SMLR ) is scheduled to announce Q4 earnings results on Tuesday, March 21st, after market close. The consensus EPS Estimate is $0.28 (-15.2% Y/Y) and the consensus Revenue Estimate is $13.1M (+13.9% Y/Y). For further ...

2023-03-20 17:35:07 ET Major earnings expected after the bell on Tuesday include: NIKE ( NKE ) GameStop ( GME ) Array Technologies ( ARRY ) AAR Corp. ( AIR ) HealthEquity ( HQY ) For further details see: Notable earnings after Tuesday's close